Form 13-F position report

THESEUS PHARMACEUTICALS INC

Reported by ALLIANCEBERNSTEIN L P

THRX CUSIP 88369M101 Manager CIK 0001109448

Reported 0 shares, down 15,620 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q1 2024
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 5 Through Q1 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-03-31 1370335
2023-06-30 2038400
2023-09-30 42018
2023-12-31 63261
2024-03-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

5 quarters
Quarterly reported position history for THESEUS PHARMACEUTICALS INC held by ALLIANCEBERNSTEIN L P.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2024 Reduced 0 -15,620 (-100.0%) 0 $0 2024-05-14
Q4 2023 Unchanged 15,620 0 (0.0%) < 0.01% $63,261 2024-02-14
Q3 2023 Reduced 15,620 -202,858 (-92.9%) < 0.01% $42,018 2023-11-14
Q2 2023 Added 218,478 +64,161 (41.6%) < 0.01% $2,038,400 2023-08-15
Q1 2023 New 154,317 +154,317 (0.0%) < 0.01% $1,370,335 2023-05-15

Who else reported the position

70 managers reported THESEUS PHARMACEUTICALS INC for Q1 2024.

Managers reporting THESEUS PHARMACEUTICALS INC in Q1 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
RHUMBLINE ADVISERS Reduced 0 -37,155 0 $0 8 qtrs
ADVISOR GROUP HOLDINGS INC Reduced 0 -6,043 0 $0 5 qtrs
AJOVista LLC Reduced 0 -9,520 0 $0 2 qtrs
UBS Group AG Reduced 0 -22,218 0 $0 6 qtrs
SG Americas Securities LLC Reduced 0 -13,212 0 $0 2 qtrs
Bank of America Corporation Reduced 0 -28,402 0 $0 10 qtrs
ROYAL BANK OF CANADA Reduced 0 -5,615 0 $0 6 qtrs
TANG CAPITAL MANAGEMENT LLC Reduced 0 -3,255,026 0 $0 2 qtrs
DENALI ADVISORS LLC Reduced 0 -103,800 0 $0 4 qtrs
TWO SIGMA ADVISERS LP Reduced 0 -17,900 0 $0 5 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2024
Filed
May 14, 2024
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.